Core Laboratories Inc.
CLB Real Time Price USDRecent trades of CLB by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by CLB's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: Perforating and tracer injection system for oilfield applications Jan. 30, 2024
-
Patent Title: Oligonucleotide-containing tracer particles for subterranean applications Sep. 19, 2023
-
Patent Title: System and method for analyzing subsurface core samples Feb. 02, 2021
-
Patent Title: System and method for a self-contained lifting device Jan. 07, 2020
-
Patent Title: System and method for a self-contained lifting device Jun. 20, 2017
-
Patent Title: Systems and methods for the determination of formation water resistivity and conductivity Sep. 23, 2014
-
Patent Title: Enhanced process for preparing core sample thin sections Dec. 13, 2011
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of CLB in WallStreetBets Daily Discussion
Recent insights relating to CLB
Recent picks made for CLB stock on CNBC
ETFs with the largest estimated holdings in CLB
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view CLB Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.